CN117835990A - 氧化镁片剂 - Google Patents

氧化镁片剂 Download PDF

Info

Publication number
CN117835990A
CN117835990A CN202280056422.3A CN202280056422A CN117835990A CN 117835990 A CN117835990 A CN 117835990A CN 202280056422 A CN202280056422 A CN 202280056422A CN 117835990 A CN117835990 A CN 117835990A
Authority
CN
China
Prior art keywords
cellulose
tablet
magnesium oxide
additive
contained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280056422.3A
Other languages
English (en)
Chinese (zh)
Inventor
山地徹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Storas Holding Co
Original Assignee
Storas Holding Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Storas Holding Co filed Critical Storas Holding Co
Publication of CN117835990A publication Critical patent/CN117835990A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202280056422.3A 2021-08-20 2022-08-09 氧化镁片剂 Pending CN117835990A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-134883 2021-08-20
JP2021134883A JP7340572B2 (ja) 2021-08-20 2021-08-20 酸化マグネシウム錠剤
PCT/JP2022/030484 WO2023022078A1 (ja) 2021-08-20 2022-08-09 酸化マグネシウム錠剤

Publications (1)

Publication Number Publication Date
CN117835990A true CN117835990A (zh) 2024-04-05

Family

ID=85240721

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280056422.3A Pending CN117835990A (zh) 2021-08-20 2022-08-09 氧化镁片剂

Country Status (6)

Country Link
US (1) US20250127725A1 (enExample)
EP (1) EP4389133A4 (enExample)
JP (2) JP7340572B2 (enExample)
CN (1) CN117835990A (enExample)
TW (1) TW202322827A (enExample)
WO (1) WO2023022078A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7742381B2 (ja) * 2023-06-21 2025-09-19 セトラスホールディングス株式会社 錠剤の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4015485B2 (ja) * 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
AR065096A1 (es) * 2007-02-01 2009-05-13 Takeda Pharmaceutical Preparacion solida
JP5499599B2 (ja) * 2008-10-01 2014-05-21 大正製薬株式会社 アセトアミノフェン含有錠剤
WO2011030659A1 (ja) * 2009-09-08 2011-03-17 協和化学工業株式会社 制酸・緩下用錠剤
TWI564008B (zh) * 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
US10166219B2 (en) * 2012-07-27 2019-01-01 Redhill Bipharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
KR20150019620A (ko) * 2013-08-14 2015-02-25 삼성디스플레이 주식회사 유기발광 표시 장치
JP6182023B2 (ja) * 2013-08-30 2017-08-16 アサヒグループ食品株式会社 酸化マグネシウム含有錠剤及びその製造方法
TWI724629B (zh) * 2018-11-16 2021-04-11 日商協和化學工業股份有限公司 緩瀉用錠劑

Also Published As

Publication number Publication date
TW202322827A (zh) 2023-06-16
EP4389133A4 (en) 2025-07-30
US20250127725A1 (en) 2025-04-24
EP4389133A1 (en) 2024-06-26
JP7340572B2 (ja) 2023-09-07
WO2023022078A1 (ja) 2023-02-23
JP2023028906A (ja) 2023-03-03
JP2023099857A (ja) 2023-07-13

Similar Documents

Publication Publication Date Title
US10426838B2 (en) Composite particles including cellulose, inorganic compound, and hydroxypropyl cellulose
WO2000078292A1 (en) Quickly disintegrating solid preparations
EP2476423A1 (en) Antacid and laxative tablet
KR20140009452A (ko) 신규한 폴리사카라이드 유도체 및 용량형
Jadhav et al. Formulation and evaluation of dispersible tablets of diltiazem hydrochloride
JP2022500450A (ja) 共処理した微結晶セルロース及び表面反応炭酸カルシウムを含む高性能賦形剤
JP4689468B2 (ja) 錠剤およびその製造方法
Ghule et al. Evaluation of Binding Properties of Evaluation of Binding Properties of Eulophia campestris Wall. Mucilage all. Mucilage
CN117835990A (zh) 氧化镁片剂
Rao et al. Design and characterization of sustained release aceclofenac matrix tablets containing tamarind seed polysaccharide
Madaan et al. Formulation and characterization of matrix tablets using mucilage of Tinospora cordifolia as natural binder
JP5442609B2 (ja) セルロース組成物
Sheth et al. DISINTEGRATING TABLET OF LORNOXICAM
Ahmed et al. Extraction and evaluation of Mangifera indica gum as a sustained release polymer in glibenclamide matrix tablets
JP7652778B2 (ja) 錠剤およびその製造方法
Eraga et al. Evaluation of fast disintegrating tablets of paracetamol prepared from a blend of croscarmellose sodium and Pleurotus tuber-regium powder
JP5160156B2 (ja) 栄養機能食品錠剤
JP7742381B2 (ja) 錠剤の製造方法
Adsare et al. TO ENHANCE THE SOLUBILITY OF IVERMECTIN WITH PHYSICAL MIXING METHOD FOR THE PREPARATION OF ORODISPERSIBLE TABLETS.
JP2006022060A (ja) 制酸・緩下用水分散液およびそのための錠剤
US20160375070A1 (en) Solid pharmaceutical compositions of brown algae
JP4822095B2 (ja) 解熱鎮痛用固形製剤
JP2019112358A (ja) 分離偏析を抑制するセルロース含有成形体
EP2826464A1 (en) Sustained release solid dosage preparations
US10696751B2 (en) Solid preparation containing alkyl cellulose and method for producing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination